| 10-Q | 2020-06-30 | Filed 2020-08-12 |
| 10-Q | 2020-03-31 | Filed 2020-05-12 |
| 10-K | 2019-12-31 | Filed 2020-03-24 |
| 10-Q | 2019-09-30 | Filed 2019-11-13 |
| 10-Q | 2019-06-30 | Filed 2019-08-12 |
| S-1 | 2019-04-26 | Public Filing |
| 8-K | 2020-08-12 | Earnings, Exhibits |
| 8-K | 2020-08-03 | Sale of Shares, Exhibits |
| 8-K | 2020-06-26 | Officers, Exhibits |
| 8-K | 2020-06-17 | |
| 8-K | 2020-06-16 | |
| 8-K | 2020-06-15 | |
| 8-K | 2020-05-12 | |
| 8-K | 2020-04-06 | |
| 8-K | 2020-03-24 | |
| 8-K | 2020-03-11 | |
| 8-K | 2020-03-05 | |
| 8-K | 2020-01-13 | |
| 8-K | 2019-12-17 | |
| 8-K | 2019-11-20 | |
| 8-K | 2019-11-13 | |
| 8-K | 2019-09-30 | |
| 8-K | 2019-08-12 | |
| 8-K | 2019-05-28 |
| Comps ($'000 TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bicycle Therapeutics (BCYC) | 200,512 | 0% | -5.3 | -17% | 116,060 | 20,735 | 2,136 | 0 | -19,699 | -19,652 | 104,558 |
| Fuse Enterprises (FSNT) | 200,164 | 86% | -191.4 | -95% | 1,099 | 2 | 1,016 | 870 | -1,046 | -1,046 | 200,124 |
| Solbright (SBRT) | 195,093 | -11% | -4.2 | -411% | 12,978 | 107,736 | 3,481 | -399 | -53,291 | -45,982 | 194,304 |
| HOOKIPA Pharma (HOOK) | 197,170 | 0% | -2.3 | -22% | 152,037 | 26,280 | 8,324 | 0 | -32,793 | -32,034 | 73,160 |
| Corvus Gold (CORVF) | 170,478 | -15.3 | -106% | 10,214 | 765 | 0 | 0 | -10,858 | -10,858 | 166,332 | |
| Union Bridge Holdings (UGHL) | 188,095 | 26% | -422.5 | -815% | 55 | 977 | 65 | 17 | -445 | -445 | 188,075 |
| IDEAYA Biosciences (IDYA) | 186,410 | -3.7 | -18% | 122,331 | 11,925 | 0 | 0 | -21,625 | -21,025 | 77,010 | |
| GrowGeneration (GRWG) | 182,705 | 29% | 57.2 | 3% | 68,417 | 15,626 | 54,349 | 16,008 | 2,341 | 2,923 | 167,194 |
| Technovative Group (TEHG) | 182,172 | 57% | -105.6 | -33% | 5,191 | 3,101 | 765 | 437 | -1,719 | -1,719 | 181,597 |
| Exagen (XGN) | 182,113 | 54% | -60.9 | -3% | 92,744 | 34,094 | 10,439 | 5,656 | -3,141 | -2,132 | 129,862 |
| Soliton (SOLY) | 179,964 | -14.9 | -130% | 9,927 | 2,745 | 0 | 0 | -12,896 | -11,529 | 171,255 | |
| Acro Biomedical (ACBM) | 177,190 | 10% | -1,443.4 | -13% | 1,081 | 133 | 3,760 | 388 | -142 | -123 | 177,189 |
| Energy & Technology (ENGT) | 177,150 | 32% | -1,446.0 | -4% | 3,954 | 9,029 | 3,101 | 984 | -143 | -122 | 177,039 |
| Kraig Biocraft Laboratories (KBLB) | 176,366 | -99.2 | -224% | 899 | 5,504 | 0 | 0 | -2,009 | -1,775 | 176,083 | |
| American BriVision (ABVC) | 175,304 | 97% | -71.6 | -38% | 7,405 | 6,675 | 602 | 584 | -2,817 | -2,434 | 174,252 |
| Vaneck Merk Gold Trust (OUNZ) | 175,193 | 8.4 | 12% | 174,523 | 0 | 0 | 0 | 20,914 | 20,914 | 175,193 | |
| Invesco DB Gold Fund (DGL) | 174,116 | 9.8 | 10% | 174,089 | 3,964 | 0 | 0 | 17,743 | 17,748 | 174,116 | |
| Fulcrum Therapeutics (FULC) | 173,470 | -2.4 | -26% | 115,956 | 13,828 | 0 | 0 | -29,711 | -29,711 | 70,781 | |
| MariMed (MRMD) | 172,389 | 39% | 23.2 | -2% | 137,056 | 54,263 | 40,412 | 15,889 | -2,498 | 9,162 | 212,127 |
| Fortem Resources (FTMR) | 191,211 | -119.9 | -1% | 143,155 | 18,644 | 0 | 0 | -1,741 | -1,603 | 192,221 |
| Balance Sheet ($'000) | 2019-06-30 | 2019-09-30 |
| Cash | 120,200 | 109,400 |
| Accounts Receivable | ||
| Inventory | ||
| PP&E | 6,922 | 6,954 |
| Assets | 133,358 | 122,331 |
| Accounts Payable | 1,080 | 763 |
| Long-Term Debt | ||
| Liabilities | 12,750 | 11,925 |
| Stockholders' Equity | 120,608 | 110,406 |
| Income Statement ($'000) | 2019-06-30 | 2019-09-30 |
| Revenue | ||
| Cost of Revenue | ||
| Gross Profit | ||
| R&D | 8,859 | 8,923 |
| SG&A | 2,376 | 2,700 |
| Tax | 0 | 0 |
| Net Income | -10,656 | -10,969 |
| Cash Flow ($'000) | 2019-06-30 | 2019-09-30 |
| Cash Operating | -10,550 | |
| Cash Investing | -38,441 | |
| Cash Financing | -276 | |